Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 2Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 2Colonic Neoplasms 2Rectal Neoplasms 1Prostate Cancer Metastatic Castration Resistant 1Mucositis 1Communicable Diseases 1Colorectal Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Aberrant Crypt Foci 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Curcumin × Clear all
NCT02944578 2024-10-29

Topical Curcumin for Precancer Cervical Lesions

Emory University

Phase 2 Terminated
7 enrolled 7 charts

Communicable Diseases, Neoplasms

NCT02300727 2019-05-31

Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy

Aurora BayCare Medical Center

Phase 1/2 Terminated
6 enrolled 4 charts
Other

Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡